Trade DXR anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Daxor Corporation (DXR) is trading at US$10.27, down 2.66% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$58.38M. Over the past 52 weeks, DXR has traded between US$8.56 and US$14.76. On Syfe you can trade DXR with $0 commission and add it to your watchlist.
| Previous close | US$10.55 |
|---|---|
| Market cap | US$58.38M |
| 52-week range | US$8.56 – US$14.76 |
| Volume | 6.79K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Daxor Corporation
DAXOR Corporation is an innovative medical instrumentation and biotechnology company. DAXOR designed and developed the BVA-100 Blood Volume Analyzer. It is the first instrument approved by the FDA to provide rapid direct measurement of a patient's true blood volume. We believe that the BVA-100 Blood Volume Analyzer has the potential to transform therapy in a broad range of surgical and medical conditions. It is our goal, working in conjunction with hospitals and clinics, to achieve that possibility. The BVA-100 is a semi-automated Blood Volume Analyzer. It is used in conjunction with a single use diagnostic kit. It is the first FDA-approved instrument to provide rapid direct measurement of a patient's blood volume.
Year: 1983
Daxor Launches Blood Testing Lab in Eastern Kansis
Jul 30, 9:27 AM · MT Newswires
Daxor Says Received US Patent for Remote Blood Volume Monitor Technology
Jun 2, 12:36 PM · MT Newswires
Daxor Corporation (DXR) stock is trading at US$10.27, -2.66% from the previous close of US$10.55.
The market cap for Daxor Corporation (DXR) stock is approximately US$58.38M.
The 52-week high for Daxor Corporation (DXR) stock is US$14.76.
The 52-week low for Daxor Corporation (DXR) stock is US$8.56.
Daxor Corporation (DXR) does not currently pay a dividend.
Stay on top of DXR
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
